Anti-infectives Portfolio
Bacterial infections
Key Facts
About Aurobindo Pharma
Aurobindo Pharma Limited is a vertically integrated pharmaceutical company founded in 1986, headquartered in Hyderabad, India. The company has established itself as a major player in the global generics market with a diverse portfolio spanning antibiotics, ARVs, CVS, CNS, gastroenterology, and other therapeutic segments. With multiple manufacturing facilities across India, the US, and other countries, Aurobindo has built a robust supply chain and regulatory compliance framework serving both developed and emerging markets.
View full company profileAbout Bliss GVS Pharma
Bliss GVS Pharma is a vertically integrated pharmaceutical company with core strengths in anti-malarials, anti-infectives, and a growing portfolio in other therapeutic areas. The company operates through its manufacturing facilities in India and has established a strong commercial footprint in over 70 countries. Its strategic direction involves expanding its product portfolio through in-house R&D and strategic partnerships, while leveraging its manufacturing capabilities to serve regulated and semi-regulated markets.
View full company profileTherapeutic Areas
Other Bacterial infections Drugs
| Drug | Company | Phase |
|---|---|---|
| Novel Antibiotics | Shionogi | Various |
| Azithromycin products | Alkem Laboratories | Commercial |
| Cefixime & Ofloxacin combinations | Ipca Laboratories | Commercial |
| Antibiotic Portfolio | SPIMACO | Approved/Commercial |
| Zevtera® (ceftobiprole medocaril) | Basilea Pharmaceutica | Approved/Commercial |
| Cephalosporin APIs (Cefixime, Cefpodoxime, etc.) | Nectar Lifesciences | Approved |
| Penicillin APIs (Amoxicillin, etc.) | Nectar Lifesciences | Approved |
| Vibativ® (telavancin) | Cleo Life Sciences | Approved |